There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific ...

Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific ...

Press release Launch of a capital increase with preferential subscription rights for nearly 5 million euros Issuance of new shares for an initial total amount of around €5.0 million, with shareholders ...

Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results.

Soligenix (NASDAQ: SNGX) is spotlighting new interim data on HyBryte(TM) (synthetic hypericin) for early-stage cutaneous T-cell ly ...

The U.S. Army Combat Capabilities Development Command Chemical Biological Center, DEVCOM CBC, and the University of ...

When executed with precision and transparency, ECAs can enhance trial efficiency, expand access and support evidence—while ...

Switching to camizestrant, a next-generation oral SERD, significantly prolongs progression-free survival and maintains ...